CORD-19:22616110b79baaf4c9d23f130a9ee35c64d991f7 / 423455-423532 JSONTXT

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T363","span":{"begin":0,"end":77},"obj":"Sentence"}],"text":"Voriconazole (VRZ) remains the first line therapy for invasive aspergillosis."}

{"project":"CORD-19-Sentences","denotations":[{"id":"T57166","span":{"begin":0,"end":77},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Voriconazole (VRZ) remains the first line therapy for invasive aspergillosis."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2394","span":{"begin":54,"end":76},"obj":"Disease"},{"id":"T2395","span":{"begin":63,"end":76},"obj":"Disease"}],"attributes":[{"id":"A2394","pred":"mondo_id","subj":"T2394","obj":"http://purl.obolibrary.org/obo/MONDO_0000240"},{"id":"A2395","pred":"mondo_id","subj":"T2395","obj":"http://purl.obolibrary.org/obo/MONDO_0005657"}],"text":"Voriconazole (VRZ) remains the first line therapy for invasive aspergillosis."}